What are the investment strengths of Tonix Pharmaceuticals Holding Corp (TNXP)?

P/B of 0.74x with 190M cash (83% of market cap) means pipeline valued near zero - any approval creates massive upside Minimal debt (0.4M) and 187M working capital provide operational flexibility rare in pre-profit biotech

What are the investment risks for Tonix Pharmaceuticals Holding Corp (TNXP)?

99M net loss TTM on 10.3M revenue - needs 10x revenue growth just to break even at current cost structure 95M stock issuance TTM (55% of market cap) signals chronic dilution - shares outstanding likely to expand further

Tonix Pharmaceuticals Holding Corp

TNXP

—

Build a strategy around TNXP

Tonix Pharmaceuticals Holding Corp AI Insights

Informational only. Not investment advice.

As of 2025-12-12

Snapshot

Cash burn of 76.3M TTM vs 190M cash = ~2.5 years runway without additional dilution[Free Cash Flow TTM]
Trading at 0.74x book value (231M equity vs 172M market cap) - market pricing in failure[Price to Book Ratio]
R&D spend of 35.8M TTM is 3.5x revenue - binary bet on pipeline success[Research and Development TTM]

Watch Triggers

Cash and Equivalents: Falls below 100M — Triggers forced financing at unfavorable terms, accelerating dilution spiral
Total Revenue TTM: Exceeds 25M quarterly run-rate — Signals commercial traction reducing dependency on capital raises
Research and Development TTM: Drops below 25M without revenue offset — May indicate pipeline abandonment or pivot away from core strategy

Bull Case

P/B of 0.74x with 190M cash (83% of market cap) means pipeline valued near zero - any approval creates massive upside

Price to Book RatioCash and Equivalents

Minimal debt (0.4M) and 187M working capital provide operational flexibility rare in pre-profit biotech

Total DebtWorking Capital

Bear Case

99M net loss TTM on 10.3M revenue - needs 10x revenue growth just to break even at current cost structure

Net Income TTMTotal Revenue TTM

95M stock issuance TTM (55% of market cap) signals chronic dilution - shares outstanding likely to expand further

Issuance of Capital StockShares Outstanding

Bull vs Bear Balance

AI-generated sentiment analysis based on fundamental metrics and market conditions.

35%

Leverage TNXP's top insights and create a custom strategy based on them in seconds. Our AI editor does it all — in one click.

Take Me to The Editor

Forward Thesis

Cash runway extends to late 2027 if burn rate stabilizes, but dilution risk remains high

1-3ymed

190M cash vs 76M annual burn
95M raised via stock issuance TTM
Near-zero debt (0.4M) preserves flexibility

FCF TTM: -76.3MStock issuance TTM: 94.9MDebt/Equity: 0.002

Valuation Context

Caveats

Public Strategies Rankings

See how Tonix Pharmaceuticals Holding Corp ranks across different investment strategies.

Leverage TNXP's top insights and create a custom strategy in seconds. Our AI editor does it all — in one click.

TNXP Fundamentals

Manufacturing → Chemical Manufacturing

Metric	Value	YoY Growth	Industry Percentile
Market Cap	$120.46M		—
Enterprise Value	$-69.17M		—
P/E Ratio	0.05		—
Total Revenue - TTM	$10.3M	-8.8%	—
Earnings Per Share (diluted) - TTM	$279.15		—
Operating Margin - TTM	-932%	-215.7%	—
Net Margin - TTM	-963%	+234.5%	—
Free Cash Flow - TTM	$-76.32M		—
Return on Common Equity - TTM	-65.0%	+73.7%	—
Beta 5Y (Monthly)	unknown		—

TNXP Dividend History

No dividends

TNXP Stock Splits

7 stock splits

02/05/25100:1 split

06/10/2432:1 split

05/10/236.25:1 split

05/17/2232:1 split

11/01/1910:1 split

11/28/1810:1 split

03/17/1710:1 split

TNXP SEC Filings

Filing Date	Report Date	Report Type	Filing Link
11/10/25	09/30/25	10-Q	0001999371-25-017370
08/11/25	06/30/25	10-Q	0001999371-25-011050
05/12/25	03/31/25	10-Q	0001999371-25-005875
03/18/25	12/31/24	Unknown	0001999371-25-002786
11/12/24	09/30/24	10-Q	0001999371-24-014569
08/16/24	06/30/24	10-Q	0001999371-24-010281
05/13/24	03/31/24	10-Q	0001999371-24-005989
04/01/24	12/31/23	10-K	0001999371-24-004297
11/09/23	09/30/23	10-Q	0001839882-23-030328
08/10/23	06/30/23	10-Q	0001387131-23-009608
05/08/23	03/31/23	10-Q	0001387131-23-006175
03/13/23	12/31/22	10-K	0001387131-23-003377
11/07/22	09/30/22	10-Q	0001387131-22-011157
08/08/22	06/30/22	10-Q	0001387131-22-008503
05/09/22	03/31/22	10-Q	0001387131-22-005860
03/14/22	12/31/21	10-K	0001387131-22-003640
11/08/21	09/30/21	10-Q	0001387131-21-010869
08/09/21	06/30/21	10-Q	0001387131-21-008266
05/10/21	03/31/21	10-Q	0001387131-21-005464
03/15/21	12/31/20	10-K	0001387131-21-003550
11/09/20	09/30/20	10-Q	0001387131-20-009688
08/10/20	06/30/20	10-Q	0001387131-20-007238
05/12/20	03/31/20	10-Q	0001387131-20-004639
03/24/20	12/31/19	10-K	0001387131-20-003189
11/08/19	09/30/19	10-Q	0001387131-19-008474
08/12/19	06/30/19	10-Q	0001387131-19-005974
05/13/19	03/31/19	10-Q	0001387131-19-003509
03/18/19	12/31/18	10-K	0001387131-19-001980
11/09/18	09/30/18	10-Q	0001615774-18-012342
08/13/18	06/30/18	10-Q	0001615774-18-007871
05/11/18	03/31/18	10-Q	0001615774-18-003618
03/09/18	12/31/17	10-K	0001615774-18-001762
11/06/17	09/30/17	10-Q	0001615774-17-006255
08/11/17	06/30/17	10-Q	0001615774-17-004278
05/12/17	03/31/17	10-Q	0001615774-17-002349
04/13/17	12/31/16	10-K	0001615774-17-001665
11/10/16	09/30/16	10-Q	0001615774-16-008154
08/05/16	06/30/16	10-Q	0001615774-16-006595
05/06/16	03/31/16	10-Q	0001144204-16-099576
03/03/16	12/31/15	10-K	0001144204-16-085821
11/06/15	09/30/15	10-Q	0001144204-15-063388
08/07/15	06/30/15	10-Q	0001144204-15-047318
05/08/15	03/31/15	10-Q	0001144204-15-028828
02/27/15	12/31/14	10-K	0001144204-15-012769
11/07/14	09/30/14	10-Q	0001144204-14-066098
08/08/14	06/30/14	10-Q	0001144204-14-048073
05/13/14	03/31/14	10-Q	0001144204-14-030020
03/28/14	12/31/13	10-K	0001144204-14-018823
11/13/13	09/30/13	10-Q	0001144204-13-061041
08/14/13	06/30/13	10-Q	0001144204-13-046004
05/07/13	03/31/13	10-Q	0001144204-13-026856
03/11/13	12/31/12	10-K	0001144204-13-014283
11/14/12	09/30/12	10-Q	0001144204-12-062620
08/13/12	06/30/12	10-Q	0001144204-12-044868
05/15/12	03/31/12	10-Q	0001144204-12-029432
11/22/13	12/31/11	10-K/A	0001144204-13-063785
03/30/12	12/31/11	10-K	0001144204-12-019081
10/07/11	09/30/11	10-Q	0001165527-11-000924
08/15/11	06/30/11	10-Q	0001165527-11-000713
05/04/11	03/31/11	10-Q	0001165527-11-000407
03/02/11	12/31/10	10-K	0001165527-11-000204
11/08/10	09/30/10	10-Q	0001165527-10-000825
08/09/10	06/30/10	10-Q	0001165527-10-000548
05/04/10	03/31/10	10-Q	0001165527-10-000341
02/16/10	12/31/09	10-K	0001165527-10-000110
11/05/09	09/30/09	10-Q	0001165527-09-000829
08/05/09	06/30/09	10-Q	0001165527-09-000515
05/12/09	03/31/09	10-Q	0001165527-09-000320
03/17/09	12/31/08	10-K	0001165527-09-000167
11/05/08	09/30/08	10-Q	0001165527-08-000670
08/14/08	06/30/08	10-Q	0001165527-08-000449
05/15/08	03/31/08	10-Q	0001165527-08-000272